BamSEC and AlphaSense Join Forces
Learn More

Cellectar Biosciences Inc. – Material Contracts

NASDAQ: CLRB    
Share price (6/3/26): $2.60    
Market cap (6/3/26): $20.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.5
from 8-K 6 pages May 4, 2026 C/O Nantahala Capital Management, LLC 130 Main Street, 2nd Floor New Canaan, Ct 06840 Re: Director Designation Rights Ladies and Gentlemen
12/34/56
EX-10.4
from 8-K 15 pages Placement Agency Agreement
12/34/56
EX-10.3
from 8-K 27 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 47 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 45 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 10 pages October 7, 2025 Holder of Common Stock Purchase Warrants Issued on October 25, 2022, July 21, 2024 and July 2, 2025 Re: Exercise of Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 5 pages Holder of Common Stock Purchase Warrants Issued on June 5, 2020, October 25, 2022 and July 21, 2024 Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder
12/34/56
EX-10.1
from 8-K 8 pages [Name] [Address] Re: Reprice and Reload Offer of Common Stock Purchase Warrants to Whom It May Concern
12/34/56
EX-10.1
from 8-K 11 pages Cellectar Biosciences, Inc. 2021 Stock Incentive Plan, as Amended
12/34/56
EX-10.1
from 8-K 64 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 11 pages Appendix a Cellectar Biosciences, Inc. 2021 Stock Incentive Plan, as Amended
12/34/56
EX-10.26
from 10-K 11 pages Material contract
12/34/56
EX-10.1
from 8-K 13 pages Director and Officer Indemnification Agreement
12/34/56
EX-10.3
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 41 pages Private Placement Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 40 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 1 to Cellectar Biosciences, Inc. 2021 Stock Incentive Plan
12/34/56
EX-10.1
from 8-K 11 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 11 pages Cellectar Biosciences, Inc. 2021 Stock Incentive Plan
12/34/56
EX-10.2
from 8-K 29 pages Registration Rights Agreement
12/34/56